Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
Jesse L BerryKaty C LiuDivakar GuptaDilraj S GrewalJoshua HornsBarbara M WirostkoBrian C StaggPublished in: BMJ open ophthalmology (2023)
Patients receiving ocular steroid injections are at risk of developing glaucoma/OHT, even with no prior glaucoma/OHT diagnosis or treatment. Patients should be closely monitored for the development of glaucoma following ocular steroid injections, particularly in the setting of intravitreal and/or repeated steroid administration.
Keyphrases
- optic nerve
- optical coherence tomography
- end stage renal disease
- platelet rich plasma
- ultrasound guided
- vascular endothelial growth factor
- blood pressure
- ejection fraction
- diabetic retinopathy
- newly diagnosed
- chronic kidney disease
- cataract surgery
- cardiovascular disease
- prognostic factors
- peritoneal dialysis
- age related macular degeneration
- health insurance
- patient reported outcomes